The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 07, 2015

Filed:

Jul. 14, 2009
Applicants:

Martha Karen Newell, Holland, TX (US);

Susannah K. Rogers, Holland, TX (US);

Inventors:

Martha Karen Newell, Holland, TX (US);

Susannah K. Rogers, Holland, TX (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/22 (2006.01); A61K 31/4409 (2006.01); A61K 31/7004 (2006.01); A61K 39/395 (2006.01); A61K 45/06 (2006.01); A61K 31/4706 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/22 (2013.01); A61K 31/4409 (2013.01); A61K 31/7004 (2013.01); A61K 39/395 (2013.01); A61K 45/06 (2013.01); A61K 2039/505 (2013.01); A61K 31/4706 (2013.01);
Abstract

Methods and products for treating proliferative diseases, and wounds, using as a pharmacon an autophagy inhibitor, a glycolytic inhibitor, and/or an agent able to alter cellular production of reactive oxygen, or combination thereof, optionally in combination with one or more chemotherapeutic agents. In some embodiments, the invention combines a 4-aminoquinoline, exemplified by chloroquine, with a glycolytic inhibitor, exemplified by 2-deoxy-D-glucose and anti-VEGF antibodies. The systems and methods of the invention may be used to treat drug-resistant or multi-drug resistant cancers.


Find Patent Forward Citations

Loading…